Megyn Kelly Makes Bold Declaration About Taylor Swift's Relationship - Yahoo
2 days ago • Google News
Boundless Bio, Inc. Common Stock (BOLD)
US$ 1.69-0.59%
Price Chart
Key Statistics
Market Cap
$ 34.34M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
97.69K
52W High
$ 12.26
52W Low
$ 1.06
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
1.6141
200-Day MA
2.707
52 Week High
12.26
52 Week Low
1.06
About BOLD
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA.
Employees
64
Headquarters
San Diego, CA
CEO
Dr. Jonathan E. Lim M.D.
Latest News
Watch The Bold and the Beautiful Season 38 Episode 154: 4/28/2025 - CBS
9 hours ago • Google News
Lakers’ bold second-half lineup adjustment worked — until it didn’t. Now what? - The New York Times
14 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg